MedTrace Logo

EmpowerHer: Hybrid Digital Intervention for Breast Cancer Survivors

NCT07676591 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 147

Last updated 2026-06-30

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if a 12-week hybrid exercise and education program (EmpowerHer) works to improve health-related quality of life in breast cancer survivors aged 35 to 65.

The main questions it aims to answer are:

* Does the EmpowerHer program improve the everyday quality of life of participants?
* Does the program lower fatigue, anxiety, and depression while raising physical fitness?

Researchers will compare the EmpowerHer program to usual medical care to see if the program works better to help survivors recover.

Participants will:

* Use a mobile application at home at least twice a week for structured exercise.
* Read short educational modules on the mobile application about health after cancer.
* Attend weekly in-person motivational group sessions with a program facilitator.
* Complete health and physical tests at the start, at 12 weeks, and 3 months later.

Conditions

  • Breast Cancer
  • Cancer Survivors
  • Quality of Life
  • Exercise Therapy
  • Social Support
  • Mobile Applications

Interventions

BEHAVIORAL

EmpowerHer Hybrid Program

A 12-week hybrid physical exercise and health education program. It consists of home-based structured exercise sessions delivered via a dedicated mobile application (minimum of 2 sessions per week) combined with weekly, in-person group motivational and educational sessions led by a trained local facilitator in community settings.

Sponsors & Collaborators

  • European Platform for Sport Innovation (EPSI)

    collaborator UNKNOWN

  • Surpass Sport Systems

    collaborator UNKNOWN

  • Olympiacos SFP

    collaborator UNKNOWN

  • Cluster Sports and Technology (CST)

    collaborator UNKNOWN

  • European Platform for Sport Innovation

    collaborator UNKNOWN

  • Poznań Supercomputing and Networking Center (PCSS)

    collaborator UNKNOWN

  • University of Valencia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2027-07-01
Primary Completion
2028-06-30
Completion
2028-06-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07676591 on ClinicalTrials.gov